Evidence map›Paper›PMID 37963808›Full record

ArticleStem cells translational medicine2024

Extracellular Vesicles From Mesenchymal Umbilical Cord Cells Exert Protection Against Oxidative Stress and Fibrosis in a Rat Model of Bronchopulmonary Dysplasia.

Paola Bisaccia, Fabio Magarotto, Stefania D'Agostino, Arben Dedja, Silvia Barbon, Diego Guidolin, Cristina Liboni, Roberta Angioni, Giada De Lazzari, Federico Caicci and 15 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. LncRNA SNHG14 drives alveolar inflammation in bronchopulmonary dysplasia via DNMT3a-mediated epigenetic silencing of miR-214-3p.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bronchopulmonary dysplasia and extremely preterm birth: time for a broader perspective on long-term outcomes.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Lung organoids: a new frontier in neonatology and paediatric respiratory medicine.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 1 institution in 1 country.

Paola BisacciaDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Fabio MagarottoDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Stefania D'AgostinoDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Arben DedjaDepartment of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Silvia BarbonDepartment of Neuroscience, University of Padova, Padova, Italy.
Diego GuidolinDepartment of Neuroscience, University of Padova, Padova, Italy.
Cristina LiboniInstitute of Pediatric Research Città della Speranza, Padova, Italy.
Roberta AngioniInstitute of Pediatric Research Città della Speranza, Padova, Italy.
Giada De LazzariDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Federico CaicciDepartment of Biology, University of Padua, Padova, Italy.
Antonella ViolaInstitute of Pediatric Research Città della Speranza, Padova, Italy.
Marcin JurgaEXO Biologics SA, Liège, Belgium.
Gabrielis KundrotasEXO Biologics SA, Liège, Belgium.ORCID 0000-0002-1222-6467
Dimitri StevensEXO Biologics SA, Liège, Belgium.
Domenico MancusoEXO Biologics SA, Liège, Belgium.
Elisabetta GramegnaEXO Biologics SA, Liège, Belgium.
Bruno SeitajEXO Biologics SA, Liège, Belgium.
Rudra KashyapEXO Biologics SA, Liège, Belgium.
Beatrice De VosEXO Biologics SA, Liège, Belgium.
Veronica MacchiDepartment of Neuroscience, University of Padova, Padova, Italy.
Eugenio BaraldiDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Andrea PorzionatoDepartment of Neuroscience, University of Padova, Padova, Italy.
Raffaele De CaroDepartment of Neuroscience, University of Padova, Padova, Italy.
Maurizio MuracaDepartment of Women's and Children's Health, University of Padova, Padova, Italy.
Michela PozzobonDepartment of Women's and Children's Health, University of Padova, Padova, Italy.ORCID 0000-0001-9213-402X
University of Padua · IT

Funding

Biothèque Hospitalo-Universitaire de LiègeEXO BiologicsEXO Biologics, BelgiumWallonie Recherche SPW
6 · The paper itself

Abstract

Oxidative stress and fibrosis are important stress responses that characterize bronchopulmonary dysplasia (BPD), a disease for which only a therapy but not a cure has been developed. In this work, we investigated the effects of mesenchymal stromal cells-derived extracellular vesicles (MSC-EVs) on lung and brain compartment in an animal model of hyperoxia-induced BPD. Rat pups were intratracheally injected with MSC-EVs produced by human umbilical cord-derived MSC, following the Good Manufacturing Practice-grade (GMP-grade). After evaluating biodistribution of labelled MSC-EVs in rat pups left in normoxia and hyperoxia, oxidative stress and fibrosis investigation were performed. Oxidative stress protection by MSC-EVs treatment was proved both in lung and in brain. The lung epithelial compartment ameliorated glycosaminoglycan and surfactant protein expression in MSC-EVs-injected rat pups compared to untreated animals. Pups under hyperoxia exhibited a fibrotic phenotype in lungs shown by increased collagen deposition and also expression of profibrotic genes. Both parameters were reduced by treatment with MSC-EVs. We established an in vitro model of fibrosis and another of oxidative stress, and we proved that MSC-EVs suppressed the induction of αSMA, influencing collagen deposition and protecting from the oxidative stress. In conclusion, intratracheal administration of clinical-grade MSC-EVs protect from oxidative stress, improves pulmonary epithelial function, and counteracts the development of fibrosis. In the future, MSC-EVs could represent a new cure to prevent the development of BPD.

Indexed as

Bronchopulmonary DysplasiaExtracellular VesiclesHyperoxiaMesenchymal Stem CellsAnimalsCollagenDisease Models, AnimalFibrosisHumansInfant, NewbornOxidative StressRatsTissue DistributionUmbilical CordCollagenbronchopulmonary dysplasiaextracellular vesicleslung fibrosismacrophagesoxidative stress

Identifiers

PMID37963808
PMCPMC10785219
OpenAlexW4388684672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.